title: The prophylaxis and treatment with antiviral agents of respiratory syncytial virus infections.
abstract: In this review, we consider recent advances in the discovery and development of antiviral agents for respiratory syncytial virus (RSV) infections. A background to the various manifestations of human RSV infection and current treatments is provided. The technical, clinical and commercial issues surrounding the development of such antiviral agents are discussed.
authors.affiliation: Biolty SL, Madrid, Spain.
authors.forename: Pilar
authors.initials: P
authors.lastname: Najarro
authors.forename: Richard
authors.initials: R
authors.lastname: Angell
authors.forename: Kenneth
authors.initials: K
authors.lastname: Powell
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D035843:Biomedical Research; D055808:Drug Discovery / Q000191:economics / Q000379:methods; D004345:Drug Industry / Q000191:economics; D006801:Humans; D008954:Models, Biological; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy* / Q000517:prevention & control*
chemical_list: D000998:Antiviral Agents